Acadian Asset Management »

Vyne Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $148k 446k 0.33
2025-06-30 $36k 22k 1.61

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
JPMorgan Chase & Co. (JPM)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Logitech Intl S A SHS (LOGI)
Broadcom Ord Shs (AVGO)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Vyne Therapeutics

Baker Bros. Advisors
Acorn Capital Advisors
Shay Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Vanguard Group
Jane Street
Geode Capital Management
Boothbay Fund Management
Bridgeway Capital Management
Susquehanna International
Two Sigma Advisers
Corsair Capital Management
Rangeley Capital

View all funds holding Vyne Therapeutics